Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02439983 · ClinicalTrials.gov registry record · NA

Brain Imaging Study

A NA study, sponsored by Pharmanex.

Completed
Registry status
NA
Development phase
68
Enrollment target

NCT02439983: Completed NA study, sponsored by Pharmanex.

NCT02439983 is a NA study that has completed, run by Pharmanex. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02439983, a NA study, has completed, sponsored by Pharmanex.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

The study is designed to evaluate the effects of the proprietary nutritional supplement on cognition, mood, and brain imaging parameters following a relatively short period of treatment.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Proprietary Nutritional Supplement

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2015-04
Est. Completion 2016-06
Phase NA

Sponsor

Pharmanex

13 total trials

What the Registry Record Tells You About NCT02439983

The ClinicalTrials.gov registry entry for NCT02439983 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pharmanex, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02439983 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02439983 about?

NCT02439983 is a clinical study titled "Brain Imaging Study". The study is designed to evaluate the effects of the proprietary nutritional supplement on cognition, mood, and brain imaging parameters following a relatively short period of treatment.

What is the current status of trial NCT02439983?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2015-04. Estimated completion is 2016-06.

What interventions are being tested in trial NCT02439983?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Proprietary Nutritional Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02439983?

This trial is sponsored by Pharmanex, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.